ACF Investors

"Sometimes out of adversity comes opportunity, and SnapDragon is testament to that. We are helping brands to remove fakes from sale online: protecting revenues, reputations and, most importantly, the end consumer. What brands may not realise is that sales made from counterfeits fund organised crime, such as trafficking – and nobody wants a fake of their brand funding illicit trade. In identifying fakes online, and removing them from sale on the pertinent platforms, we prevent their visibility and subsequent purchase, export, import and distribution."

"With this investment, our investors have affirmed the strength of our technology and its commercial potential. Building upon years of research, this funding will drive the development of our platform, facilitate the rollout of our own range of therapeutics and expand our team. As our recent collaboration with the UCL Drug Discovery Institute has shown, we are beginning to have a potent effect on the pharmaceutical industry and I am looking forward to the many ways in which we can make a decisive contribution to medicine worldwide"

"Since Cavalry’s release in August 2020 we’ve been blown away with the variety and quality of work being produced by our global community. This capital will help us further accelerate Cavalry’s development and to explore new ways for us to enable animators, designers and marketers to meet the demands of an ever-expanding media landscape."

"We’re delighted to have secured significant investment from both existing and new investors as we seek to drive sales of INSIGHT,"

"I am really pleased to work with ACF for a second time to bring their support to Axis Spine. It is a great example of the UK ecosystem supporting fantastic entrepreneur-led medtech companies and I am delighted to assist Jon and the Axis team take their superior products to market and to build out the underlying platform."